Article Versions Notes

Lien C-F, Wang C-C, Yang C-C, Wang C-C, Hwang T-Z, Shih Y-C, Yeh S-A, Hsieh M-C. Platinum Plus Tegafur–Uracil versus Platinum Alone during Concurrent Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma: A Propensity-Score-Matching Analysis. Cancers. 2022; 14(18):4511. https://doi.org/10.3390/cancers14184511

Lien, Ching-Feng, Chien-Chung Wang, Chuan-Chien Yang, Chih-Chun Wang, Tzer-Zen Hwang, Yu-Chen Shih, Shyh-An Yeh, and Meng-Che Hsieh. 2022. "Platinum Plus Tegafur–Uracil versus Platinum Alone during Concurrent Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma: A Propensity-Score-Matching Analysis" Cancers 14, no. 18: 4511. https://doi.org/10.3390/cancers14184511

Lien, C.-F., Wang, C.-C., Yang, C.-C., Wang, C.-C., Hwang, T.-Z., Shih, Y.-C., Yeh, S.-A., & Hsieh, M.-C. (2022). Platinum Plus Tegafur–Uracil versus Platinum Alone during Concurrent Chemoradiotherapy in Patients with Nonmetastatic Nasopharyngeal Carcinoma: A Propensity-Score-Matching Analysis. Cancers, 14(18), 4511. https://doi.org/10.3390/cancers14184511